Summary & Overview
HCPCS G8971: Oral Anticoagulant Not Prescribed, Reason Not Given
HCPCS Level II code G8971 denotes that warfarin or another FDA-approved oral anticoagulant was not prescribed and no reason was provided. The code documents an omission in anticoagulation prescribing when an oral agent would otherwise be relevant to the patient’s care. Nationally, use of this code is important for quality measurement, medication safety monitoring, and payer adjudication because it signals potential gaps in guideline-concordant therapy or documentation lapses.
Payors covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of what G8971 represents, the clinical contexts in which it is applied, and how payers typically view documentation for anticoagulant initiation or non-initiation. The publication summarizes benchmark concepts, documentation expectations tied to coverage and quality programs, and the clinical rationale that commonly surrounds decisions not to prescribe oral anticoagulation.
This summary is intended for national audiences including clinicians, billing and coding staff, compliance officers, and policy analysts. It outlines the code’s purpose, common sites of service tied to anticoagulation management, and the types of insights organizations can pursue when G8971 appears in claims data. Data not available in the input.
Billing Code Overview
HCPCS Level II code G8971 indicates that warfarin or another FDA-approved oral anticoagulant was not prescribed and no reason was documented. The code captures a situation where an indicated oral anticoagulant therapy was not initiated or prescribed, without an accompanying explanation.
-
Service type: Medication management / anticoagulation decision documentation
-
Typical site of service: Outpatient clinical setting (office, clinic) where anticoagulation decisions are made
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with atrial fibrillation or a prior venous thromboembolism for whom long-term oral anticoagulation would ordinarily be indicated but an FDA‑approved oral anticoagulant such as warfarin or a direct oral anticoagulant (DOAC) is documented as not prescribed and no reason is recorded. The scenario often appears during an office visit, medication reconciliation, or annual medication review when the clinician documents anticoagulation is not prescribed but fails to record the clinical rationale (for example, perceived bleeding risk, patient refusal, access or cost concerns, or pending shared decision‑making). Workflow steps include medication reconciliation by nursing staff, clinician review of stroke or VTE risk (CHA2DS2‑VASc, HAS‑BLED), shared decision discussion, and documentation of the plan. The service is typically coded at the time of the encounter to capture that an indicated FDA‑approved oral anticoagulant was not prescribed and no justification is provided.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure | Use when an E/M visit is performed in addition to a procedure or distinct service on the same day |
59 |